GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Decipher Labs Ltd (BOM:524752) » Definitions » YoY EBITDA Growth

Decipher Labs (BOM:524752) YoY EBITDA Growth : 140.99% (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Decipher Labs YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Decipher Labs's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 140.99%.

Decipher Labs's EBITDA per Share for the three months ended in Mar. 2024 was ₹1.48.


Decipher Labs YoY EBITDA Growth Historical Data

The historical data trend for Decipher Labs's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decipher Labs YoY EBITDA Growth Chart

Decipher Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 392.21 49.25 234.50 -124.16 83.64

Decipher Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -230.56 -102.16 -212.92 101.69 140.99

Decipher Labs YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Decipher Labs's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (A: Mar. 2024 )
=(EBITDA per Share (A: Mar. 2024 )-EBITDA per Share (A: Mar. 2023 ))/ | EBITDA per Share (A: Mar. 2023 ) |
=(-0.536--3.277)/ | -3.277 |
=83.64 %

Decipher Labs's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(1.478--3.606)/ | -3.606 |
=140.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Decipher Labs YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Decipher Labs's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Decipher Labs (BOM:524752) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, 4th Floor, Plot No. 94, Sagar Society, Banjara Hills, Hyderabad, TG, IND, 500034
Decipher Labs Ltd, formerly Combat Drugs Ltd is an India-based company engaged in the trading and manufacturing of Pharmaceutical drugs. It also undertakes contract manufacturing services business. The group generates revenue from the sale of its pharmaceutical products.

Decipher Labs (BOM:524752) Headlines

No Headlines